S.F. Leitman

909 citations
7 papers · 678 · 1 hit paper · h-index 5

Impact in

  • Immunology top 10%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
  • Oncology top 10%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers

Papers in

S.F. Leitman

7 papers receiving 617 citations

S.F. Leitman's Hit Papers

Prospective Randomized Trial of High-Dose Interleukin-2 Alone or in Conjunction With Lymphokine-Activated Killer Cells for the Treatment of Patients With Advanced Cancer 1993 · 499 citations
4990+11+22Years since publication100200300400

Peers

S.F. Leitman
Comparison fields: 5 of 67
  • Immunology 312
  • Oncology 334
  • Biochemistry 65
  • Hematology 82
  • Pulmonary and Respiratory Medicine 98
Replace Yusuke Makiguchi with:
Yusuke Makiguchi Japan
M Masuda Japan
Mark S. Brower United States
Ch. Salmon France
Valerie Relias United States
Miguel H. Bronchud Spain
José Manuel Cózar Spain
Wilhelm Wößmann Germany
Rong‐Miao Zhou China
Idanna Innocenti Italy
S.F. Leitman relative to Yusuke Makiguchi Japan Yusuke Makiguchi's profile →
Citations per field
00.5×2×4×6×7.5×
Yusuke Makiguchi · 1×
Citations per year

Countries citing papers authored by S.F. Leitman

Since Specialization
Citations

This map shows the geographic impact of S.F. Leitman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.F. Leitman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.F. Leitman more than expected).

Fields of papers citing papers by S.F. Leitman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.F. Leitman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.F. Leitman. The network helps show where S.F. Leitman may publish in the future.

Co-authors

The 25 scholars most cited alongside S.F. Leitman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S.F. Leitman Line = papers co-authored together S.F. Leitman links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1
Prospective Randomized Trial of High-Dose Interleukin-2 Alone or in Conjunction With Lymphokine-Activated Killer Cells for the Treatment of Patients With Advanced Cancer
Hit paper breakdown →
1993499
2 199297
3 199540
4 198721
5 199317
6 20042
7 19942

About S.F. Leitman

S.F. Leitman is a scholar working on Hematology, Pediatrics, Perinatology and Child Health, Oncology, Surgery and Anesthesiology and Pain Medicine, having authored 7 papers that have together received 678 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (4 papers), Neonatal Health and Biochemistry (2 papers), Airway Management and Intubation Techniques (1 paper), Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Anesthesia and Pain Management (1 paper), Immunotherapy and Immune Responses (1 paper) and Erythrocyte Function and Pathophysiology (1 paper). The work is most often cited by research in Immunology (312 citations), Oncology (334 citations), Biochemistry (65 citations), Hematology (82 citations) and Pulmonary and Respiratory Medicine (98 citations). S.F. Leitman has collaborated with scholars based in United States, Malaysia and Ukraine. Frequent co-authors include Claudia A. Seipp, Paul Aebersold, W. Marston Linehan, Douglas J. Schwartzentruber, Michael T. Lotze, Suzanne L. Topalian, Seth M. Steinberg, S A Rosenberg, Jin‐Hao Yang and Richard J. Davey. Their work appears in journals such as Transfusion, JNCI Journal of the National Cancer Institute, Cancer Immunology Immunotherapy, Blood and Biology of Blood and Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact